Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.

Federal Judge Refuses to Nix Lawsuit Over Gilead HIV Drugs

A federal judge has refused to dismiss a lawsuit that claims Gilead Sciences, Inc. purposely delayed development of a safer HIV drug for years, merely to protect profits from sales of tenofovir disoproxil fumarate, or TDF. History of Gilead HIV … Continue reading

FDA Panel Meeting to Address Surgical Stapler Injuries

The U.S. Food & Drug Administration (FDA) will convene an advisory panel meeting later this month to address injuries and complications associated with the use of surgical staplers and internal staple systems. The two-day meeting of the General & Plastic … Continue reading

Baby Powder Lawsuits, Other Big Litigations Weigh on Johnson & Johnson Earnings

Johnson & Johnson earnings were down in first quarter of 2019, as Baby Powder lawsuits and other big product liability litigations continued to weigh on the company’s bottom line. According to Johnson & Johnson’s latest quarterly filing, net earnings fell … Continue reading

Louisiana MultiHance Lawsuit Alleges Gadolinium Toxicity After Multiple MRIs

The manufacturer of MultiHance is facing yet another lawsuit over Gadolinium Deposition Disease, an incurable and debilitating disorder that allegedly occurs after the administration of gadolinium-based MRI contrast agents. MultiHance Lawsuit Allegations According a complaint filed in the U.S. District … Continue reading

Valsartan Recall Defendants Ordered to Produce Core Discovery Materials

Core discovery has begun in the  U.S. District Court, District of New Jersey, where all product liability lawsuits related to ongoing recalls of generic valsartan medications were recently centralized for coordinated pretrial proceedings According to an Order dated April 29th, valsartan … Continue reading

Taxotere Hair Loss Court Prepping for Upcoming Bellwether Trial

Hundreds of Taxotere hair loss claims continue to move forward in the U.S. District Court, Eastern District of Louisiana, where the first bellwether trial will likely get underway ithis fall. First Taxotere Lawsuit Heads to Trial on September 16th The … Continue reading

Bard Hernia Mesh Litigation Convenes April Status Conference

Hundreds of hernia mesh lawsuits filed against C.R. Bard, Inc. and its Davol, Inc. subsidiary continue to move forward in the U.S. District Court, Southern District of Ohio, where the most recent Status Conference was convened on April 17th. Bard … Continue reading

Court Outlines Plaintiffs’ Leadership Structure for 3M Military Earplugs Litigation

Hundreds of product liability claims involving the 3M Company’s allegedly defective Combat Arms Earplugs continue to move forward in the U.S. District, Northern District of Florida. According to an Order dated April 19th, the plaintiffs’ leadership structure will consist of … Continue reading

Valsartan Lawsuit Court Allows Direct Filing in Federal Litigation

The federal court overseeing dozens of valsartan lawsuits has approved a new order allowing plaintiffs to file cases directly in the U.S. District Court, District of New Jersey. Direct filing will eliminates delays associated with transferring a cases to the … Continue reading

Medicare Patients More Likely to Receive IVC Blood Clot Filters, Despite Overall Decline

While fewer Americans are receiving IVC blood clot filters, a new study suggests that the devices are far more prevalent among Medicare patients compared to those with private insurance. Complications from IVC Blood Clot Filters IVC filters are implanted in … Continue reading

Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest